<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Abnormal one-carbon metabolism may lead to general genomic (global) hypomethylation, which may predispose an individual to the development of colorectal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We evaluated the association between pre-diagnostic leukocyte genomic DNA methylation level and the risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in a nested case-control study of 358 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases and 661 matched controls within the <z:hpo ids='HP_0000001'>all</z:hpo>-female cohort of the Nurses' Health Study (NHS) </plain></SENT>
<SENT sid="2" pm="."><plain>Among control subjects, we further examined major plasma components in the one-carbon metabolism pathway in relation to genomic DNA methylation level </plain></SENT>
<SENT sid="3" pm="."><plain>Liquid chromatography/tandem mass spectrometry was used to examine leukocyte genomic DNA methylation level </plain></SENT>
<SENT sid="4" pm="."><plain>We calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) using logistic regression </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Overall genomic DNA methylation level was not associated with the risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (p for trend, 0.45) </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with women in the lowest quintile of methylation, the multivariate OR of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk was 1.32 (95% CI, 0.82-2.13) for those in the highest quintile </plain></SENT>
<SENT sid="7" pm="."><plain>We did not find significant associations between major plasma components of one-carbon metabolism or risk factors for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and genomic DNA methylation level (<z:hpo ids='HP_0000001'>all</z:hpo> p for trend &gt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Also, neither one-carbon metabolism-related plasma components nor well-known risk factors for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> modified the association between genomic DNA methylation level and the risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> p for interaction &gt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We found no evidence that hypomethylation of leukocyte genomic DNA increases risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> among women </plain></SENT>
<SENT sid="10" pm="."><plain>Additional studies are needed to investigate the association between pre-diagnostic genomic DNA methylation level and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk among diverse populations </plain></SENT>
</text></document>